Sign in

CIK 0001253689 · Non-accelerated filer<br>Smaller reporting company

CRESCENT BIOPHARMA, INC.

Sign in to watch
Ticker
CBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Cayman Islands
Entity type
operating
Phone
617-430-5595
Business address
300 FIFTH AVENUE, WALTHAM, MA, 02451
Former names
GLYCOMIMETICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$285,501
in 7 filings, $286K under 10b5-1 plans

Net −$285,501. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Brumm Joshua T −$160K Chief Executive Officer sold 3% of stake
  2. McNeill Jonathan −$77K President and COO sold 3% of stake
  3. Pinkas Jan −$12K Chief Scientific Officer sold 3% of stake
  4. Im Ellie Eunkyung −$11K Chief Medical Officer sold 3% of stake
  5. Bispham Barbara Harlin −$11K See Remarks sold 3% of stake

Reading 48 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-01-20 Thackray Helen M. SVP Clinical Development, CMO Grant or award · Employee Stock Option (right to buy) +69,000 69,000
2021-01-20 Magnani John L. SVP of Research, CSO Grant or award +34,500 324,260
2021-01-20 Magnani John L. SVP of Research, CSO Grant or award · Employee Stock Option (right to buy) +69,000 69,000
2021-01-20 King Rachel K. President, CEO Grant or award +96,250 452,314
2021-01-20 King Rachel K. President, CEO Grant or award · Employee Stock Option (right to buy) +192,500 192,500
2020-12-28 King Rachel K. President, CEO Option exercise +130,821 $1.12 $147K 440,240
2020-12-28 King Rachel K. President, CEO Sale −84,176 $3.91 $329K 356,064
2020-12-28 King Rachel K. President, CEO Option exercise · Employee Stock Option (right to buy) −130,821 0
2020-12-16 Hahn Brian M. SVP Finance, CFO Option exercise +5,260 $1.12 $6K 5,260
2020-12-16 Hahn Brian M. SVP Finance, CFO Option exercise · Employee Stock Option (right to buy) −5,260 0
2020-11-04 BVF PARTNERS L P/IL 10% owner Purchase +674,492 $2.60 $1.8M 4,980,812
2020-11-04 BVF PARTNERS L P/IL 10% owner Purchase +506,155 $2.60 $1.3M 3,712,350
2020-11-04 BVF PARTNERS L P/IL 10% owner Purchase +86,090 $2.60 $224K 630,453
2020-10-30 BVF PARTNERS L P/IL 10% owner Purchase +666,385 $2.75 $1.8M 4,306,320
2020-10-30 BVF PARTNERS L P/IL 10% owner Purchase +250,755 $2.75 $690K 3,206,195
2020-10-30 BVF PARTNERS L P/IL 10% owner Purchase +15,472 $2.75 $43K 544,363
2020-05-22 JUNIUS DANIEL M Director Grant or award · Stock Option (right to buy) +21,000 21,000
2020-05-22 PEARSON TIMOTHY R Director Grant or award · Stock Option (right to buy) +21,000 21,000
2020-05-22 Koenig Scott Director Grant or award · Stock Option (right to buy) +21,000 21,000
2020-05-22 Jackson Scott Thomas Director Grant or award · Stock Option (right to buy) +21,000 21,000

Page 10 of 16 · 305 trades